“I think it’s really important that people keep signing up to these type of trials to push research forward.”
A study to find genes that may increase thyroid cancer risk
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
In this study people who had thyroid cancer or thyroid growths had blood taken and completed questionnaires to find genes that may increase risk of thyroid cancer.
More about this trial
We know from research that genetic factors may affect the risk of thyroid cancer.
In this study, the researchers looked at the
They looked for common gene faults that may have increased thyroid cancer risk. They also found out more about the patients’ family history to see if any of their relatives also had thyroid cancer.
The aim of the study was to identify genes that might have increased the risk of thyroid cancer.
Summary of results
One of the genes the team looked at is called HABP2 G534E.
The researchers asked 2,105 people with thyroid cancer to
- complete a questionnaire
- give a blood sample
They used the blood samples to find out how many of them had the HABP2 G534E gene.
The team also looked at 5,172 people from the general population to see how many of them had the HABP2 G534E gene.
When they looked at the results for the 2 groups the team found similar numbers of people had the HABP2 G534E gene in both groups.
So the researchers concluded that the HABP2 G534E gene wasn’t likely to increase the risk of thyroid cancer.
The study team are continuing to identify other genes that may increase the risk. When these results are published we will update this summary.
We have based this summary on information from the research team. The information they sent us has been reviewed by independent specialists (
How to join a clinical trial
Professor Ian Tomlinson
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Oxford